A national randomised multi-centre phase II/III trial using MesoPher in ABC borderline resectable pancreatic cancer (PREOPANC-6 trial)
14395
Phase 3 other active
Quick answer
A national randomised multi-centre phase II/III trial using MesoPher in ABC borderline resectable pancreatic cancer (PREOPANC-6 trial) for ABC borderline resectable pancreatic cancer is a Phase 3 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- ABC borderline resectable pancreatic cancer
- Phase
- Phase 3
- Modality
- other
- Status
- active